These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 11058868)

  • 1. Identification of differentially expressed genes in human melanoma cells with acquired resistance to various antineoplastic drugs.
    Grottke C; Mantwill K; Dietel M; Schadendorf D; Lage H
    Int J Cancer; 2000 Nov; 88(4):535-46. PubMed ID: 11058868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human melanoma cell lines selected in vitro displaying various levels of drug resistance against cisplatin, fotemustine, vindesine or etoposide: modulation of proto-oncogene expression.
    Kern MA; Helmbach H; Artuc M; Karmann D; Jurgovsky K; Schadendorf D
    Anticancer Res; 1997; 17(6D):4359-70. PubMed ID: 9494534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of DNA repair proteins hMSH2, hMSH6, hMLH1, O6-methylguanine-DNA methyltransferase and N-methylpurine-DNA glycosylase in melanoma cells with acquired drug resistance.
    Lage H; Christmann M; Kern MA; Dietel M; Pick M; Kaina B; Schadendorf D
    Int J Cancer; 1999 Mar; 80(5):744-50. PubMed ID: 10048977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of gene expression profiles in melanoma cells with acquired resistance against antineoplastic drugs.
    Györffy B; Serra V; Materna V; Schäfer R; Dietel M; Schadendorf D; Lage H
    Melanoma Res; 2006 Apr; 16(2):147-55. PubMed ID: 16567970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Candidate genes for cross-resistance against DNA-damaging drugs.
    Wittig R; Nessling M; Will RD; Mollenhauer J; Salowsky R; Münstermann E; Schick M; Helmbach H; Gschwendt B; Korn B; Kioschis P; Lichter P; Schadendorf D; Poustka A
    Cancer Res; 2002 Nov; 62(22):6698-705. PubMed ID: 12438269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated expression of S100P, CAPL and MAGE 3 in doxorubicin-resistant cell lines: comparison of mRNA differential display reverse transcription-polymerase chain reaction and subtractive suppressive hybridization for the analysis of differential gene expression.
    Bertram J; Palfner K; Hiddemann W; Kneba M
    Anticancer Drugs; 1998 Apr; 9(4):311-7. PubMed ID: 9635921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations of DNA repair in melanoma cell lines resistant to cisplatin, fotemustine, or etoposide.
    Rünger TM; Emmert S; Schadendorf D; Diem C; Epe B; Hellfritsch D
    J Invest Dermatol; 2000 Jan; 114(1):34-9. PubMed ID: 10620112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DFNA5 (ICERE-1) contributes to acquired etoposide resistance in melanoma cells.
    Lage H; Helmbach H; Grottke C; Dietel M; Schadendorf D
    FEBS Lett; 2001 Apr; 494(1-2):54-9. PubMed ID: 11297734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of differentially expressed mRNA transcripts in drug-resistant versus parental human melanoma cell lines.
    Tanic N; Brkic G; Dimitrijevic B; Dedovic-Tanic N; Gefen N; Benharroch D; Gopas J
    Anticancer Res; 2006; 26(3A):2137-42. PubMed ID: 16827156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Demonstration of differential gene expression between sensitive and resistant ovarian tumor cells by fluorescence differential display-PCR analysis.
    Li L; Luan Y; Li X; Tang B; Zhang W; Li D; Zhao J; Wang G; Ding H; Reed E; Li QQ
    Oncol Rep; 2005 May; 13(5):793-9. PubMed ID: 15809740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Doxorubicin-resistant variants of human prostate cancer cell lines DU 145, PC-3, PPC-1, and TSU-PR1: characterization of biochemical determinants of antineoplastic drug sensitivity.
    David-Beabes GL; Overman MJ; Petrofski JA; Campbell PA; de Marzo AM; Nelson WG
    Int J Oncol; 2000 Dec; 17(6):1077-86. PubMed ID: 11078791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug resistance towards etoposide and cisplatin in human melanoma cells is associated with drug-dependent apoptosis deficiency.
    Helmbach H; Kern MA; Rossmann E; Renz K; Kissel C; Gschwendt B; Schadendorf D
    J Invest Dermatol; 2002 Jun; 118(6):923-32. PubMed ID: 12060385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study of the development of chemoresistance in melanoma cell lines using proteome analysis.
    Sinha P; Poland J; Kohl S; Schnölzer M; Helmbach H; Hütter G; Lage H; Schadendorf D
    Electrophoresis; 2003 Jul; 24(14):2386-404. PubMed ID: 12874874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The altered apoptotic pathways in cisplatin and etoposide-resistant melanoma cells are drug specific.
    Kissel CK; Schadendorf D; Röckmann H
    Melanoma Res; 2006 Dec; 16(6):527-35. PubMed ID: 17119454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of genomic imbalances with resistance to therapeutic drugs in human melanoma cell lines.
    Nessling M; Kern MA; Schadendorf D; Lichter P
    Cytogenet Cell Genet; 1999; 87(3-4):286-90. PubMed ID: 10702697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene expression profiling of drug-resistant small cell lung cancer cells by combining microRNA and cDNA expression analysis.
    Guo L; Liu Y; Bai Y; Sun Y; Xiao F; Guo Y
    Eur J Cancer; 2010 Jun; 46(9):1692-702. PubMed ID: 20371173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acquired resistance of melanoma cells to the antineoplastic agent fotemustine is caused by reactivation of the DNA repair gene MGMT.
    Christmann M; Pick M; Lage H; Schadendorf D; Kaina B
    Int J Cancer; 2001 Apr; 92(1):123-9. PubMed ID: 11279615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic analyses identify gene candidates for acquired irinotecan resistance in melanoma cells.
    Gao K; Lockwood WW; Li J; Lam W; Li G
    Int J Oncol; 2008 Jun; 32(6):1343-9. PubMed ID: 18497997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel mutant topoisomerase II alpha present in VP-16-resistant human melanoma cell lines has a deletion of alanine 429.
    Campain JA; Gottesman MM; Pastan I
    Biochemistry; 1994 Sep; 33(37):11327-32. PubMed ID: 7727383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of DNA topoisomerase II activity and expression in melanoma cells with acquired drug resistance.
    Lage H; Helmbach H; Dietel M; Schadendorf D
    Br J Cancer; 2000 Jan; 82(2):488-91. PubMed ID: 10646909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.